Sorayya KHEIROURI, Parinaz KALEJAHI, Seyyed Gholamreza NOORAZAR

Plasma levels of serotonin, gastrointestinal symptoms, and sleep problems in children with autism

Background/aim: Autism is a neurodevelopmental disorder identified with higher frequency of serotonin abnormalities and gastrointestinal (GI) and sleep problems. This study aimed to evaluate the plasma levels of serotonin, GI symptoms, and sleep problems, and their relationship with autism severity in children with autism. Materials and methods: Thirty-five children with autism and 31 healthy subjects were studied. GI problems, sleep disorders, and severity of disorder were assessed. Plasma serotonin was determined using ELISA. Results: There was no significant association between GI problems and autism severity, but a significant positive correlation was seen between different indicators of sleep disorder and severity of autism. Plasma levels of serotonin were significantly higher in autistic children and a significant negative correlation was observed between plasma levels of serotonin and autism severity (r = 0.39, P = 0.02). Conclusion: Elevated plasma serotonin in autistic children and its negative correlation with disease severity may indicate involvement of the neurotransmitter in the neurophysiologic mechanism of autism.

PDF

___

1. Lord C, Cook E, Leventhal B, Amaral D. Autism spectrum disorders. Neuron 2000; 28: 355-363.
2. Molloy C, Manning-Courtney P. Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism 2003; 7: 165-171.
3. Ibrahim SH, Voigt R, Katusic S, Weaver A. Barbers WJ. Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics 2009; 124: 680- 686.
4. Patzold L, Richdale A, Tonge BJ. An investigation into sleep characteristics of children with autism and Aspergers disorder. J Paediatr Child Health 1998; 34: 528-533.
5. Schreck K, Mulick J, Smith A. Sleep problems as possible predictors of intensified symptoms of autism. Res Dev Disabil 2004; 25: 57-66.
6. Polimeni M, Richdale A, Francis A. A survey of sleep problems in autism, Aspergers disorder and typically developing children. J Intellect Dis Res 2005; 49: 260-268.
7. Horvath K, Perman J. Autistic disorder and gastrointestinal disease. Curr Opin Pediatre 2002; 14: 583-587.
8. Mannion A, Leader G. An investigation of comorbid psychological disorders, sleep problems, gastrointestinal symptoms and epilepsy in children and adolescents with autism spectrum disorder. Res Autism Spect Dis 2013; 7: 35- 42.
9. Melmed R, Schneider C, Fabes R, Phillips L, Reichelt K. Metabolic markers and gastrointestinal symptoms in children with autism and related disorders. J Pediatr Gastroenterol Nutr 2000; 31: S31-32.
10. Richdale A, Schreck K. Sleep problems in autism spectrum disorders: prevalence, nature, & possible biopsychosocial aetiologies. Sleep Med Rev 2009; 13: 403-411.
11. Hoshino Y, Watanabe H, Yashima Y. An investigation on sleep disturbance of autistic children. Psychiatry Clin Neurosci 1984; 38: 45-51.
12. Hanley H, Stahl S, Freedman D. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen 1977; 34: 521-531.
13. Schain R, Freedman D. Studies on 5-hydroxy indole metabolism in autistic and other mentally retarded children. J Pediatr 1961; 58: 315-320.
14. Kane MJ, Angoa-Peréz M, Briggs DI, Sykes CE, Francescutti DM, Rosenberg DR, Kuhn DM. Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PLoS One 2012; 7.
15. Sato K. Placenta-derived hypo-serotonin situations in the developing forebrain cause autism. Med Hypotheses 2013; 80: 368-372
16. Meguid NA, Gebril OH, Khalil RO. A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children. Adv Biomed Res 2015; 4: 94.
17. Gabriele S, Sacco R, Persico AM. Blood serotonin levels in autism spectrum disorder: a systematic review and metaanalysis. Eur Neuro Psycho Pharmacol 2014; 24: 919-929.
18. Murphy D, Lesch K. Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci 2008; 9: 85-96.
19. Zalsman G, Aslanov-Farbstein D, Rehavi M, Roz N, Vermeiren R, Laor N, Weizman A, Toren P. Platelet vesicular mono amine transporter 2 density in the disruptive behavior disorders. J Child Adolesc Psycho Pharmacol 2011; 21: 341-344.
20. Malow B, Adkins KW, Mc Grew SG, Wang L, Goldman S, Fawkes D, Burnette C. Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord 2012; 42: 1729-1737.
21. Gringras P, Gamble C, Jones AP, Wiggs L. Melatonin for sleep problems in children with neurodevelopmental disorders: randomized, double masked placebo controlled trial. BMJ 2012; 5: 345.
22. Ursin R. The effects of 5-hydroxy tryptophan and l-tryptophan on wakefulness and sleep patterns in the cat. Brain Res 1976; 106: 105-115.
23. Touret M, Sarda N. The role of 5-hydroxytryptophan (5-HTP) in the regulation of the sleep/wake cycle in parachlorophenylalanine (p-CPA) pretreated rat: a multiple approach study. Exp Brain Res 1991; 86: 117-124.
24. Costedio M, Hyman N, Mawe G. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 2007; 50: 376-388.
25. Keszthelyi D, Troost F. Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function. Neurogastroenterology & Motility 2009; 21: 1239-1249.
26. Nikolov R, Bearss K, Lettinga J, Erickson C. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord 2009; 30: 405-413.
27. Christison G, Ivany K. Elimination diets in autism spectrum disorders: any wheat amidst the chaff? J Dev Behav Pediat 2007; 27: 162-171.
28. Kuddo T, Nelson K. How common are gastrointestinal disorders in children with autism? Curr Opin Pediatr 2003; 15: 339-343.
29. Rapin I. Autism. New Engl J Med 1997; 10: 97-104.
30. Niehus R, Lord C. Early medical history of children with autism spectrum disorders. J Dev Behav Pediatr 2006; 27: 120- 127.
31. Horvath K, Perman J. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 2002; 4: 251-258.
32. Sandler RH. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000; 15: 429-435.
33. Daoust A, Limoges E, Bolduc C, Mottron L, Godbout R. EEG spectral analysis of wakefulness and REM sleep in high functioning autistic spectrum disorders. Clin Neurophysiol 2004; 115: 1368-1373.
34. Tudor M, Hoffman C, Sweeny C. Children with autism sleep problems and symptom severity. Focus Autism Other Dev Stud 2012; 27: 254-262.
35. Hranilovic D, Bujas-Petkovic Z, Vragovic R, Vuk T, Hock K, Jernej B. Hyperserotonemia in adults with autistic disorder. J Autism Dev Disord 2007; 37:1934-1940.
36. Nagwa AM, Ola HG, Rehab OK. A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children. Adv Biomed Res 2015; 4: 94.
37. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 2010; 67: 59-68.
38. Croonenberghs J, Verkerk R, Scharpe S, Deboutte D, Maes M. Serotonergic disturbances in autistic disorder: L-5-hydroxy tryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Life Sciences 2005; 76: 2171-2183.
39. Januonis S. Serotonergic paradoxes of autism replicated in a simple mathematical model. Med Hypo 2005; 64:742-750.
40. Cook J, Leventhal B. The serotonin system in autism. Curr Opin Pediatr 1996; 8: 348-354.
41. Nabi R, Serajee F, Chugani D, Zhong H, Huq M. Association of tryptophan 2, 3 dioxygenase gene polymorphism with autism. American Journal of Medical Genetics Part B. Neuropsychiatr Genet 2004; 125: 63-68.
42. Mostafa G, Sherif E, Rasha H. Hyperserotonemia in Egyptian autistic children: relation to allergic manifestations. J Pediatr Neurol 2008; 6: 227-236.
43. Cohen I. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Gen 2003; 64: 190- 197.
44. Monti JM. Serotonin control of sleep-wake behavior. Sleep Med Rev 2011; 15: 269-281.